Delivery Order SPE2DB24D1107-SPE2DB25FZGR5
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $50K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count packaging) under a firm fixed-price arrangement. The contract, valued at $7,553.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 29, 2025. AmerisourceBergen will perform fulfillment operations from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,377.96 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count package) under a firm fixed-price contract. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Latuda 20 mg tablets (30-count) valued at $4,191.82 under a firm fixed-price contract. The award was made on May 14, 2025, with an ultimate completion date of May 15, 2025, and the product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on September 25, 2025, with a ceiling value of $19,403.50. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Latuda 60 mg tablets in quantities of 30 units, with a contract ceiling value of $3,132.62. This firm fixed-price delivery order is non-competitive and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The contract is scheduled for completion by April 22, 2025, and will be fulfilled from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Latuda 60 mg, a medication used to treat bipolar disorder and schizophrenia, valued at $3,040.56. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $9,844.52 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction under the company's broader pharmaceutical supply relationships with the federal government. The product will be delivered to AmerisourceBergen's...